The Liver Meeting® 2019

5 (5 votes)

View on-demand presentations from The Liver Meeting® 2019 in Boston. The Liver Meeting® is AASLD’s largest meeting covering a variety of trending topics. 

  • Contains 6 Component(s) Recorded On: 11/11/2019

    Women's Health Program: Pregnancy in Liver Disease presented at The Liver Meeting® 2019.

    How can women with liver diseases or organ transplants have healthier pregnancies? Careful, multidisciplinary management is key. This session will provide key updates in this area, covering topics like contraception use and pregnancy management across a spectrum of liver diseases, including the liver transplant population.

    Natalie Bzowej
    Christine Doligalski
    Michael Heneghan
    Monika Sarkar
    Kidist Yimam

  • Contains 6 Component(s) Recorded On: 11/10/2019

    Value-based Medicine in Hepatology: Defining the Role of Hepatologists in Value-based Care presented at The Liver Meeting® 2019.

    Value-Based Arrangements are increasingly becoming part of the healthcare landscape. The goal of this program is to educate and empower hepatologists to be valuable contributors to the success of these new arrangements and play an active role in developing and implementing beneficial approaches.

    Meena Bansal
    Ziad Gellad
    Arpan Patel
    Grace Su
    Michael Volk

  • Contains 11 Component(s) Recorded On: 11/09/2019

    Transplant Surgery Workshop: : Liver Transplantation for NASH: Optimizing Outcomes presented at The Liver Meeting® 2019.

    Nonalcoholic steatohepatitis has become a leading indication for liver transplantation in the United States and worldwide. At this symposium, faculty will review pre-transplant evaluation and assessment of comorbid conditions in these patients, early and long-term challenges after transplantation, patterns of recurrence of the disease and potentially preventive strategies.

    Alfred Sidney Barritt IV
    Tayyab Diwan
    Jean Emond
    Ibrahim A. Hanouneh
    Timucin Taner
    Monica A. Tincopa
    Lisa B. VanWagner
    Kymberly Watt

  • Contains 2 Component(s) Recorded On: 11/10/2019

    Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture: Clinical Vs Science in Personalizing Immunosuppression presented at The Liver Meeting® 2019.

    Immunosuppression in the liver transplant setting includes multiple drugs aimed at predetermined trough levels, adjusted to time after transplantation. Excellent graft and patient survival supports immunosuppression, but there may be significant short- and long-term risks. At this presentation, experts will discuss clinical approaches to immunosuppression in liver transplant patients, including biomarkers used for safe personalization of this process.

    David Mulligan
    Abraham Shaked

  • Product not yet rated Contains 5 Component(s) Recorded On: 11/08/2019

    Public Health/ Healthcare Delivery SIG: Population Screening for Liver Disease Worldwide presented at The Liver Meeting® 2019.

    This timely program tackles the eternal question of how to best screen for liver disease in the general population. Speakers will take a global perspective to describe novel methods of screening, discuss high-risk patient populations and address issues of cost effectiveness and linkage to care.

    Maya Balakrishnan
    Fasiha Kanwal
    W. Ray Kim
    Andrew Yeoman

  • Contains 2 Component(s) Recorded On: 11/10/2019

    President's Choice Lecture presented at The Liver Meeting® 2019.

    In the world's poorest nations, the appalling loss of life from easily treated or preventable illnesses represents a moral tragedy. This year's President's Choice Lecture explores potential strategies to correct this inequity, including collaborative partnerships among medical professionals, ways to accurately measure the impact of global disease management efforts and the innovative solutions necessary to accomplish this great task.

    Michael Fried
    Tadataka Yamada

  • Contains 3 Component(s) Recorded On: 11/08/2019

    Non-alcoholic Fatty Liver Disease SIG: NAFLD Progression: A Cross Talk with Microbiome presented at The Liver Meeting® 2019.

    At this symposium, experts share the latest advances in the research of the microbiome and its relationship with NAFLD. They will discuss the microbiome’s association with disease progression, fibrosis and hepatocellular carcinoma. Topics covered will include the “cross talk” between obesity, the microbiome and NAFLD in both animal models and humans.

    John Y.L. Chiang
    Vanessa Leone

  • Contains 3 Component(s) Recorded On: 11/10/2019

    NIH Corner: NAFLD Progression: New Horizons in HCC, NASH and Viral Hepatitis presented at The Liver Meeting® 2019.

    Several NIH institutes showcase programs, innovations and opportunities to the AASLD membership at this informative event. Representatives of the NCI, NIDDK, NIAID and NIAAA will present areas of mutual interest to the institute and AASLD membership, including liver cancer, NASH, viral hepatitis and alcohol use disorder. This is a unique opportunity to learn more about interagency collaboration and funding opportunities.

    Jo Ann Rinaudo
    Gary Murray

  • Product not yet rated Contains 6 Component(s) Recorded On: 11/10/2019

    Maintenance of Certification (MOC) Update: Acute on Chronic Liver Failure presented at The Liver Meeting® 2019.

    Discuss the current state of the ABIM Maintenance of Certification (MOC) program for gastroenterologists and transplant hepatologists at this update. Speakers will review the expense, time commitment and relevance of this program’s requirements; current MOC requirements in the program; the means to meet these requirements; progress made in addressing concerns from ABIM diplomats; and alternative pathways to board recertification.

    Ryan M. Kwok
    Paul Mathew
    Heather M. Patton
    Mark W. Russo
    Richard K. Sterling

  • Contains 7 Component(s) Recorded On: 11/11/2019

    Liver Transplantation and Surgery SIG & Pediatric Liver Disorders SIG: Optimizing Allograft Health Over a Lifetime presented at The Liver Meeting® 2019.

    Discover how allocation impacts long-term outcomes for the transplant recipient and liver graft at this session. Speakers will address ways to improve the ability to interpret and identify the significance of long-term, post-transplant liver biopsy findings and offer tools to expand one’s perspective on individualizing immunosuppression to optimize long-term outcomes for the allograft and recipient.

    Sandy Feng
    Evelyn K. Hsu
    Deirdre A. Kelly
    Jennifer C. Lai
    Josh Levitsky
    Jacqueline G. O'Leary